SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 25, 17:00
582.80
21.5 (3.83%)
VOLUME 230,107
LIVE
NSE
Jul 25, 17:00
583.10
20.7 (3.68%)
VOLUME 1,461,816
Management Interviews on Ranbaxy Laboratories
Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
See more drug price caps; max impact on Sanofi: Expert 

10.09 am | 16 Jul 2014 |  Source: CNBC-TV18

NPPA has cut and capped prices of some major anti-diabetes and cardiovascular drugs that were not part of the 652 drugs earlier listed out by the gove...

See prices of cardiac drugs reduce by 15-50%: Ex-MD Pfizer 

12.12 pm | 14 Jul 2014 |  Source: CNBC-TV18

According to Kewal Handa, the pricing regulator (NPPA) has fixed prices of medicines that are not included in the national list of essential medicines...

Will look to close Ranbaxy deal by year-end: Sun Pharma 

2.00 pm | 30 Jun 2014 |  Source: CNBC-TV18

According to Uday Baldota of Sun Pharma winning CNBC-TV18's CFO award in the pharma and healthcare space is recognition of the company's good performa...

Nexium generic next big opportunity for Ranbaxy: Angel 

3.02 pm | 27 Jun 2014 |  Source: CNBC-TV18

Given the Sun-Ranbaxy merger, Nangra sees an upside potential of 8-10 percent in Ranbaxy....

USFDA boost for Ranbaxy; see akin deal for Nexium: Dandekar 

9.08 am | 27 Jun 2014 |  Source: CNBC-TV18

After a long stretch of regulatory hassles, Vikas Dandekar of PharmAsiaNews.Com believes the worst is behind for the pharma major with this USFDA boos...

1
Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.